Docetaxel-based adjuvant therapy for breast cancer patients in Asia-Pacific region: Results from 5 years follow-up on Asia-Pacific Breast Initiative-I

Aim To acquire patient characteristics, safety, relapse and survival outcomes of early‐stage breast cancer patients receiving docetaxel (Taxotere(R))‐based regimen in adjuvant setting from the Asia‐Pacific region. Methods This was an open‐label, international, longitudinal, multicenter, observationa...

Ausführliche Beschreibung